FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steffi Oesterreich

Research Profile

Disorders

Breast Neoplasms

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Mouse

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Matthew J Sikora; David J Dabbs; Rachel C Jankowitz; Steffi Oesterreich
Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems.
N Lynn Henry; Kelley Kidwell; Lang Li; Anne T Nguyen; Steffi Oesterreich; Santosh Philips; James M Rae; Todd C Skaar; Vered Stearns; Anna Maria Storniolo; Janet S Carpenter; Jessica Dantzer; Zeruesenay Desta; Christina Gersch; Daniel F Hayes; David A Flockhart
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.
Francesmary Modugno; Courtney L Andersen; Paul Haluska; Robin Laskey; Ashlee L Smith; Steffi Oesterreich
Hormone response in ovarian cancer: time to reconsider as a clinical target?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steffi Oesterreich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Matthew J Sikora; David J Dabbs; Rachel C Jankowitz; Steffi Oesterreich
Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems.
Steroids 2013;78(6):568-75.
2013: N Lynn Henry; Kelley Kidwell; Lang Li; Anne T Nguyen; Steffi Oesterreich; Santosh Philips; James M Rae; Todd C Skaar; Vered Stearns; Anna Maria Storniolo; Janet S Carpenter; Jessica Dantzer; Zeruesenay Desta; Christina Gersch; Daniel F Hayes; David A Flockhart
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.
Breast cancer research and treatment 2013;138(3):807-16.
2012: Francesmary Modugno; Courtney L Andersen; Paul Haluska; Robin Laskey; Ashlee L Smith; Steffi Oesterreich
Hormone response in ovarian cancer: time to reconsider as a clinical target?
Endocrine-related cancer 2012;19(6):R255-79.
2012: Carolyn L Smith; Meng-Fen Wu; Margaret C Pace; Vaishali Chaubal; Dean P Edwards; M Carolina Gutiérrez; Ryan Hartmaier; Susan G Hilsenbeck; Shiming Jiang; Ilenia Migliaccio; Steffi Oesterreich
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
Breast cancer research and treatment 2012;136(1):253-65.
2012: Jasmina Z Cerne; Susan G Hilsenbeck; Jaroslav Jelinek; Steffi Oesterreich; Tao Wang; Lin Zong; Sean E McGuire
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.
Breast cancer research and treatment 2012;135(1):135-43.
2012: Santosh Philips; James M Rae; Alexandra Richter; David A Flockhart; Steffi Oesterreich; Narayanan B Perumal; Todd C Skaar
Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene.
Hormones & cancer 2012;3(1-2):37-43.
2012: R J Hartmaier; J Hayden; Daniel F Hayes; N Lynn Henry; A V Lee; L Li; S E McGuire; A T Nguyen; Bert W O'Malley; C K Osborne; S Philips; James M Rae; A S Richter; J Z Sallit; T C Skaar; Vered Stearns; J Wang; J Xu; Faouzi Azzouz; P H Brown; D A Flockhart; R M Gillihan; Steffi Oesterreich
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.) 2012;26(2):220-7.
2012: Angelo J Casa; Chad J Creighton; Susan G Hilsenbeck; Hee-Tae Kim; Isere Kuiatse; Zawaunyka Lazard; Simeen Malik; Steffi Oesterreich; Adam S Potter; Anna Tsimelzon; Powell H Brown; Adrian V Lee
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
Breast cancer research and treatment 2012;132(1):61-73.
2012: Claudia Coronnello; Ryan Hartmaier; Luai Huleihel; Naftali Kaminski; Steffi Oesterreich; Kusum V Pandit; Gary D Stormo; Arshi Arora; Abha S Bais; Michael Butterworth; Panayiotis V Benos
Novel modeling of combinatorial miRNA targeting identifies SNP with potential role in bone density.
PLoS computational biology 2012;8(12):e1002830.
2012: Rebecca J Watters; Panayiotis V Benos; Steffi Oesterreich
To bind or not to bind--FoxA1 determines estrogen receptor action in breast cancer progression.
Breast cancer research : BCR 2012;14(3):312.
2012: Santosh Philips; James M Rae; Vered Stearns; Anna Maria Storniolo; David A Flockhart; Daniel F Hayes; N Lynn Henry; Steffi Oesterreich; Todd C Skaar
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes.
Frontiers in pharmacology 2012;3():54.
2012: Hatice Ulku Osmanbeyoglu; Steffi Oesterreich; Ryan J Hartmaier; Xinghua Lu
Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information.
BMC genomics 2012;13 Suppl 1():S1.
2011: Thushangi N Pathiraja; Priya B Shetty; Ryan Hartmaier; Rong He; Susan G Hilsenbeck; Jean-Pierre J Issa; Jaroslav Jelinek; Astrid L Margossian; Steffi Oesterreich
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(12):4177-86.
2011: Jason P Garee; Rene Meyer; Steffi Oesterreich
Co-repressor activity of scaffold attachment factor B1 requires sumoylation.
Biochemical and biophysical research communications 2011;408(4):516-22.
2011: Yi Huang; Rachel Jankowitz; Shweta Nayak; Nancy E Davidson; Steffi Oesterreich
Epigenetics in breast cancer: what's new?
Breast cancer research : BCR 2011;13(6):225.
2010: Stephanie Hammerich-Hille; Valerie J Bardout; Susan G Hilsenbeck; C Kent Osborne; Steffi Oesterreich
Low SAFB levels are associated with worse outcome in breast cancer patients.
Breast cancer research and treatment 2010;121(2):503-9.
2010: Robert K Dearth; David A Delgado; Jill K Hiney; Thushangi Pathiraja; Steffi Oesterreich; Dan Medina; W Les Dees; Adrian V Lee
Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(3):312-21.
2010: Thushangi N Pathiraja; Vered Stearns; Steffi Oesterreich
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Journal of mammary gland biology and neoplasia 2010;15(1):35-47.
2010: Stephanie Hammerich-Hille; Benny A Kaipparettu; Anna Tsimelzon; Chad J Creighton; Shiming Jiang; Jose M Polo; Ari Melnick; Rene Meyer; Steffi Oesterreich
SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.
The Journal of biological chemistry 2010;285(6):3608-16.
2010: Steffi Oesterreich
San Antonio breast cancer symposium--32nd annual meeting.
IDrugs : the investigational drugs journal 2010;13(2):80-1.
2010: Jason P Garee; Steffi Oesterreich
SAFB1's multiple functions in biological control-lots still to be done!
Journal of cellular biochemistry 2010;109(2):312-9.
2010: Simeen Malik; Shiming Jiang; Jason P Garee; Eric Verdin; Adrian V Lee; Bert W O'Malley; Mao Zhang; Narasimhaswamy S Belaguli; Steffi Oesterreich
Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM.
Molecular and cellular biology 2010;30(2):399-412.
2009: Ryan J Hartmaier; Sandrine Tchatchou; Alexandra S Richter; Jay Wang; Sean E McGuire; Todd C Skaar; James M Rae; Kari Hemminki; Christian Sutter; Nina Ditsch; Peter Bugert; Bernhard H F Weber; Dieter Niederacher; Norbert Arnold; Raymonda Varon-Mateeva; Barbara Wappenschmidt; Rita K Schmutzler; Alfons Meindl; Claus R Bartram; Barbara Burwinkel; Steffi Oesterreich
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
BMC cancer 2009;9():438.
2009: Benny Abraham Kaipparettu; Klaudia M Dobrzycka; Ora Britton; Adrian V Lee; Alan J Herron; Yi Li; Michael Lewis; Daniel Medina; Steffi Oesterreich
Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis.
Molecular cancer 2009;8():15.
2008: Benny Abraham Kaipparettu; Isere Kuiatse; Bonita Tak-Yee Chan; Meju Benny Kaipparettu; Adrian V Lee; Steffi Oesterreich
Novel egg white-based 3-D cell culture system.
BioTechniques 2008;45(2):165-8, 170-1.
2008: Benny Abraham Kaipparettu; Simeen Malik; Santhi D Konduri; Wensheng Liu; Rokavec Matjaz; Heiko van der Kuip; Reiner Hoppe; Stephanie Hammerich-Hille; Peter Fritz; Werner Schroth; Ina Abele; Gokul M Das; Steffi Oesterreich; Hiltrud Brauch
Estrogen-mediated downregulation of CD24 in breast cancer cells.
International journal of cancer. Journal international du cancer 2008;123(1):66-72.
2008: James M Rae; Todd C Skaar; Susan G Hilsenbeck; Steffi Oesterreich
The role of single nucleotide polymorphisms in breast cancer metastasis.
Breast cancer research : BCR 2008;10(1):301.
2006: Steven M Townson; Kaiyan Kang; Adrian V Lee; Steffi Oesterreich
Novel role of the RET finger protein in estrogen receptor-mediated transcription in MCF-7 cells.
Biochemical and biophysical research communications 2006;349(2):540-8.
2006: Klaudia M Dobrzycka; Kaiyan Kang; Shiming Jiang; Rene Meyer; Pulivarthi H Rao; Adrian V Lee; Steffi Oesterreich
Disruption of scaffold attachment factor B1 leads to TBX2 up-regulation, lack of p19ARF induction, lack of senescence, and cell immortalization.
Cancer research 2006;66(16):7859-63.
2006: Shiming Jiang; Rene Meyer; Kaiyan Kang; C Kent Osborne; Jiemin Wong; Steffi Oesterreich
Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
Molecular endocrinology (Baltimore, Md.) 2006;20(2):311-20.
2005: Margarita Ivanova; Klaudia M Dobrzycka; Shiming Jiang; Kai Michaelis; Rene Meyer; Kaiyan Kang; Brian Adkins; Oleg A Barski; Simeen Zubairy; Jana Divisova; Adrian V Lee; Steffi Oesterreich
Scaffold attachment factor B1 functions in development, growth, and reproduction.
Molecular and cellular biology 2005;25(8):2995-3006.
2005: Simeen Zubairy; Steffi Oesterreich
Estrogen-repressed genes -- key mediators of estrogen action?
Breast cancer research : BCR 2005;7(4):163-4.
2004: Steven M Townson; Kaiyan Kang; Adrian V Lee; Steffi Oesterreich
Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain.
The Journal of biological chemistry 2004;279(25):26074-81.
2004: Adrian V Lee; Gary C Chamness; Steffi Oesterreich
26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.
Breast cancer research : BCR 2004;6(2):E10.
2003: Klaudia M Dobrzycka; Steven M Townson; Shiming Jiang; Steffi Oesterreich
Estrogen receptor corepressors -- a role in human breast cancer?
Endocrine-related cancer 2003;10(4):517-36.
2003: Steffi Oesterreich
Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?
Journal of cellular biochemistry 2003;90(4):653-61.
2003: Steffi Oesterreich; Wanleng Deng; Shiming Jiang; Xiaojiang Cui; Margarita Ivanova; Rachel Schiff; Kaiyan Kang; Darryl L Hadsell; Jürgen Behrens; Adrian V Lee
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Cancer research 2003;63(17):5203-8.
2003: Adrian V Lee; P Zhang; Margarita Ivanova; Sharon Bonnette; Steffi Oesterreich; Jeffrey M Rosen; Sandra L Grimm; Russell C Hovey; Barbara K Vonderhaar; C R Kahn; Daniel Torres; Jessy George; Syed K Mohsin; D Craig Allred; Darryl L Hadsell
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.
Endocrinology 2003;144(6):2683-94.
2003: Steven M Townson; Klaudia M Dobrzycka; Adrian V Lee; Mamie Air; Wanleng Deng; Kaiyan Kang; Shiming Jiang; Noriyuki Kioka; Kai Michaelis; Steffi Oesterreich
SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.
The Journal of biological chemistry 2003;278(22):20059-68.
2003: Xiaojiang Cui; Ping Zhang; Wanleng Deng; Steffi Oesterreich; Yiling Lu; Gordon B Mills; Adrian V Lee
Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Molecular endocrinology (Baltimore, Md.) 2003;17(4):575-88.
2003: Adrian V Lee; Rachel Schiff; Xiaojiang Cui; Deepali Sachdev; Douglas Yee; Andrew P Gilmore; Charles H Streuli; Steffi Oesterreich; Darryl L Hadsell
New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):516S-23S.
2001: Adrian V Lee; Xiaojiang Cui; Steffi Oesterreich
Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12 Suppl):4429s-4435s; discussion 4411s-4412s.
2001: Steffi Oesterreich; P Zhang; Rebecca L Guler; X Sun; Edward M Curran; Wade V Welshons; C Kent Osborne; Adrian V Lee
Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Cancer research 2001;61(15):5771-7.
2001: Steffi Oesterreich; D C Allredl; Syed K Mohsin; Q Zhang; H Wong; Adrian V Lee; C Kent Osborne; Peter O'Connell
High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.
British journal of cancer 2001;84(4):493-8.
2000: Steffi Oesterreich; Q P Zhang; Adrian V Lee
Inhibition of oestrogen receptor activity by the co-repressor HET/SAF-B is relieved by blockade of histone deacetylase activity.
European journal of cancer (Oxford, England : 1990) 2000;36 Suppl 4():S43-4.
2000: Steven M Townson; T Sullivan; Q Zhang; Gary M Clark; C Kent Osborne; Adrian V Lee; Steffi Oesterreich
HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3788-96.
2000: Steffi Oesterreich; Q Zhang; Torsten A Hopp; Suzanne A W Fuqua; M Michaelis; H H Zhao; James Davie; C Kent Osborne; Adrian V Lee
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
Molecular endocrinology (Baltimore, Md.) 2000;14(3):369-81.
2000: Adrian V Lee; Jennifer L Gooch; Steffi Oesterreich; Rebecca L Guler; D Yee
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.
Molecular and cellular biology 2000;20(5):1489-96.
1999: Steffi Oesterreich; Suzanne A W Fuqua
Tumor suppressor genes in breast cancer.
Endocrine-related cancer 1999;6(3):405-19.
1999: P Lemieux; J Harvey; Theresa A Guise; Mark Dallas; Steffi Oesterreich; J j Yin; Katri S Selander; S Fuqua
Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(9):1570-5.
1999: Rhonda K Hansen; Irma Parra; P Lemieux; Steffi Oesterreich; Susan G Hilsenbeck; Suzanne A W Fuqua
Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.
Breast cancer research and treatment 1999;56(2):187-96.
1998: SK Samuel; Virginia A Spencer; L Bajno; Jian-Min Sun; Laurel T Holth; Steffi Oesterreich; James Davie
In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells.
Cancer research 1998;58(14):3004-8.
1998: Allen E Eskenazi; J Powers; J Pinkas; Steffi Oesterreich; S A Fuqua; Christopher Frantz
Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis.
Clinical & experimental metastasis 1998;16(3):283-90.
1997: Steffi Oesterreich; Adrian V Lee; T M Sullivan; SK Samuel; James Davie; Suzanne A W Fuqua
Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells.
Journal of cellular biochemistry 1997;67(2):275-86.
1997: Rhonda K Hansen; Steffi Oesterreich; P Lemieux; K D Sarge; Suzanne A W Fuqua
Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells.
Biochemical and biophysical research communications 1997;239(3):851-6.
1997: C G Castles; Steffi Oesterreich; R Hansen; Suzanne A W Fuqua
Auto-regulation of the estrogen receptor promoter.
The Journal of steroid biochemistry and molecular biology 1997;62(2-3):155-63.
1997: Q X Zhang; Ake Borg; D M Wolf; Steffi Oesterreich; Suzanne A W Fuqua
An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.
Cancer research 1997;57(7):1244-9.
1997: P Lemieux; Steffi Oesterreich; JA Lawrence; P S Steeg; S G Hilsenbeck; J M Harvey; S A Fuqua
The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells.
Invasion & metastasis 1997;17(3):113-23.
1997: BR DuPont; DK Garcia; T M Sullivan; Susan Naylor; Steffi Oesterreich
Assignment of SAFB encoding Hsp27 ERE-TATA binding protein (HET)/scaffold attachment factor B (SAF-B) to human chromosome 19 band p13.
Cytogenetics and cell genetics 1997;79(3-4):284-5.
1996: Steffi Oesterreich; Susan G Hilsenbeck; Daniel R Ciocca; D Craig Allred; Gary M Clark; Gary C Chamness; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1199-206.
1996: Steffi Oesterreich; E Hickey; Lee A Weber; Suzanne A W Fuqua
Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells.
Biochemical and biophysical research communications 1996;222(1):155-63.
1994: Suzanne A W Fuqua; M G Benedix; S Krieg; C N Weng; Gary C Chamness; Steffi Oesterreich
Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells.
Breast cancer research and treatment 1994;32(2):177-86.
1994: Suzanne A W Fuqua; Steffi Oesterreich; Susan G Hilsenbeck; Daniel Von Hoff; J Eckardt; C Kent Osborne
Heat shock proteins and drug resistance.
Breast cancer research and treatment 1994;32(1):67-71.
1993: Daniel R Ciocca; Steffi Oesterreich; Gary C Chamness; W L McGuire; Suzanne A W Fuqua
Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.
Journal of the National Cancer Institute 1993;85(19):1558-70.
1993: Steffi Oesterreich; C N Weng; M Qiu; Susan G Hilsenbeck; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Cancer research 1993;53(19):4443-8.
1993: R Molina; Steffi Oesterreich; J L Zhou; A K Tandon; G M Clark; D C Allred; Alan J Townsend; Jeffrey A Moscow; K H Cowan; W L McGuire
Glutathione transferase GST pi in breast tumors evaluated by three techniques.
Disease markers 1993;11(2-3):71-82.